Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Thermo Fisher Merges With Life Tech
by Ann M. Thayer
February 10, 2014
| A version of this story appeared in
Volume 92, Issue 6
Thermo Fisher Scientific has completed its $13.6 billion acquisition of Life Technologies. The Federal Trade Commission granted the final approval after requiring Thermo Fisher to divest its cell culture (sera and media), gene modulation (siRNA reagents), and magnetic beads businesses. In early January, Thermo Fisher had agreed to sell the three businesses to GE Healthcare for $1.1 billion to satisfy European regulators. Life Technologies is now part of a new Thermo Fisher business called Life Sciences Solutions, headed by former Life Tech Chief Operating Officer Mark Stevenson.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter